English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

The unusual association of COVID-19 with severe hemostatic dysregulation and derangements, specifically SARS-CoV-2-induced thromboemboliccomplications,will remainachallenging task both to clinicians1–7 and basic scientists.8,9 Importantly, elucidation of disease-related molecular mechanisms and thrombo-inflammatorypathways involvedwill allow to identify specific targets for therapeutic interventions in order to reduce morbidity and mortality of COVID-19 patients8,9. Now, as the year is approaching its end, it appears to be reasonable to share some of the Journal’s achievements and highlights during the past 12 months with you. The editorial team of Hämostaseologie – Progress in Haemostasis has tried to do its very best to provide our loyal readers with attractive research articles authored by distinguished scientists in the field. Overall, for the first time in its 40-year history, Hämostaseologie – Progress in Haemostasis is publishing six issues per year, including a supplement of the Hamburg Haemophilia Symposium.

A kaleidoscope of selected contributions to hemostasis and thrombosis – an introduction and some editorial remarks